Dolomanov clinic - Company finances
|
EUR
|
2023
From: 2023-02-07
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 62,319 | 244,496 | 522,171 |
| Profit before tax | - | - | - |
| Net profit | 26,070 | 40,156 | 56,177 |
| Equity | 28,570 | 47,807 | 103,984 |
| Liabilities | 1,293 | 50,400 | 11,001 |
| Non-current assets | 37,947 | 88,768 | 89,138 |
| Current assets | 2,567 | 10,194 | 25,547 |
| Total assets | 40,514 | 98,962 | 114,685 |
|
Taxes paid
|
|||
| STI taxes | 3,305 | 13,506 | 36,428 |
| Social insurance contributions | 5,509 | 17,192 | 28,701 |
|
Financial indicators
|
|||
| Revenue change y/y | - | +292.3% | +113.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 64.3% | 40.6% | 49.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 91.2% | 84.0% | 54.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 41.8% | 16.4% | 10.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 1.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 13,219 | 37,139 | 44,440 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Dolomanov clinic - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-23 | 2026-08-23 | 277.99 |
| 2026-08-19 | 2026-08-19 | 277.99 |
| 2026-08-16 | 2026-08-16 | 63.18 |
| 2026-07-24 | 2026-08-14 | 63.18 |
| 2026-07-23 | 2026-07-23 | 8666.27 |
| 2026-07-19 | 2026-07-22 | 8603.09 |
| 2026-07-16 | 2026-07-17 | 8603.09 |
| 2026-07-15 | 2026-07-15 | 4272.88 |
| 2026-05-17 | 2026-05-26 | 4312.31 |
| 2026-05-03 | 2026-05-14 | 11.81 |
| 2026-04-28 | 2026-04-29 | 11.81 |
| 2026-04-27 | 2026-04-27 | 4338.12 |
| 2026-04-26 | 2026-04-26 | 4326.31 |
| 2026-04-24 | 2026-04-25 | 4338.12 |
| 2026-04-20 | 2026-04-23 | 4326.31 |
| 2026-03-17 | 2026-03-27 | 4108.87 |
| 2026-03-15 | 2026-03-16 | 2.31 |
| 2026-02-18 | 2026-03-11 | 2.31 |
| 2026-01-22 | 2026-02-01 | 24.99 |
| 2026-01-21 | 2026-01-21 | 20.86 |
| 2026-01-16 | 2026-01-20 | 14.88 |
| 2025-12-16 | 2025-12-17 | 13.47 |
| 2025-11-18 | 2025-11-20 | 2886.27 |
| 2025-10-24 | 2025-11-02 | 2.35 |
| 2025-10-23 | 2025-10-23 | 3036.82 |
| 2025-10-17 | 2025-10-22 | 3034.47 |
| 2025-10-16 | 2025-10-16 | 3107.10 |
| 2025-09-16 | 2025-09-24 | 336.95 |
| 2025-08-28 | 2025-08-29 | 303.81 |
| 2025-08-19 | 2025-08-25 | 303.81 |
| 2025-07-24 | 2025-08-04 | 5.67 |
| 2025-07-16 | 2025-07-23 | 320.61 |
| 2025-06-19 | 2025-06-25 | 1100.00 |
| 2025-06-17 | 2025-06-18 | 2923.64 |
| 2025-05-16 | 2025-05-25 | 240.36 |
| 2025-05-04 | 2025-05-07 | 85.49 |
| 2025-04-30 | 2025-04-30 | 82.87 |
| 2025-04-28 | 2025-04-29 | 85.49 |
| 2025-04-27 | 2025-04-27 | 84.98 |
| 2025-04-26 | 2025-04-26 | 82.87 |
| 2025-04-24 | 2025-04-25 | 85.49 |
| 2025-04-16 | 2025-04-23 | 82.87 |
| 2025-03-18 | 2025-03-26 | 968.67 |
| 2024-06-18 | 2024-06-25 | 1000.00 |
| 2024-05-16 | 2024-06-16 | 2.96 |
| 2024-04-23 | 2024-05-14 | 6.72 |
| 2024-04-16 | 2024-04-22 | 2.96 |
| 2024-02-19 | 2024-02-25 | 1082.02 |
| 2024-01-23 | 2024-02-01 | 35.86 |
| 2024-01-16 | 2024-01-22 | 34.88 |
| 2023-12-18 | 2024-01-04 | 34.88 |
| 2023-11-16 | 2023-11-19 | 112.00 |
| 2023-10-24 | 2023-11-02 | 112.00 |
| 2023-10-17 | 2023-10-23 | 111.87 |
| 2023-07-18 | 2023-07-23 | 65.08 |
Dolomanov clinic - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Dolomanov clinic is: 363 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-02 | 2026-09-02 | 363.1 |
| 2026-08-19 | 2026-09-01 | 665.11 |
| 2026-07-17 | 2026-07-26 | 302.63 |
| 2026-01-16 | 2026-02-01 | 1.62 |
| 2025-12-05 | 2025-12-15 | 1.62 |
| 2025-11-20 | 2025-12-04 | 3.67 |
| 2025-11-18 | 2025-11-19 | 373.04 |
| 2025-11-06 | 2025-11-17 | 2.79 |
| 2025-11-02 | 2025-11-05 | 13.09 |
| 2025-10-17 | 2025-11-01 | 1550.79 |
| 2025-10-05 | 2025-10-16 | 2.97 |
| 2025-10-02 | 2025-10-04 | 8.85 |
| 2025-09-17 | 2025-10-01 | 1.71 |
| 2025-08-21 | 2025-09-14 | 1.71 |
| 2025-08-19 | 2025-08-20 | 360.0 |
| 2025-08-06 | 2025-08-12 | 49.69 |
| 2025-08-02 | 2025-08-05 | 48.6 |
| 2025-07-31 | 2025-08-01 | 4226.12 |
| 2025-07-17 | 2025-07-30 | 4219.31 |
| 2025-06-19 | 2025-07-16 | 0.1 |
| 2025-06-18 | 2025-06-18 | 361.5 |
| 2025-06-17 | 2025-06-17 | 3360.0 |
| 2025-05-28 | 2025-06-05 | 11.54 |
| 2025-05-17 | 2025-05-27 | 1.86 |
| 2025-05-01 | 2025-05-16 | 1.82 |
| 2025-04-17 | 2025-04-23 | 362.67 |
| 2025-04-02 | 2025-04-16 | 2.67 |
| 2025-03-31 | 2025-04-01 | 2.07 |
| 2025-03-26 | 2025-03-30 | 1.9 |
| 2025-03-20 | 2025-03-25 | 357.04 |
| 2025-03-19 | 2025-03-19 | 3105.25 |
| 2025-02-26 | 2025-03-18 | 0.34 |
| 2025-02-25 | 2025-02-25 | 1.65 |
| 2025-02-23 | 2025-02-24 | 2070.38 |
| 2025-02-20 | 2025-02-22 | 2068.73 |
| 2025-02-19 | 2025-02-19 | 2043.72 |
| 2025-02-18 | 2025-02-18 | 3438.16 |
| 2025-02-17 | 2025-02-17 | 3337.13 |
| 2025-02-16 | 2025-02-16 | 308.69 |
| 2025-02-15 | 2025-02-15 | 308.33 |
| 2025-02-02 | 2025-02-14 | 310.73 |
| 2025-01-17 | 2025-02-01 | 308.25 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Dolomanov clinic, UAB (code 306241121) is a Private Limited Liability Company operating in dental practice care activities. In 2025, the latest financial year, the company generated revenue of €522.2K and net profit of €56.2K, resulting in a profit margin of 10.8%. Revenue grew by 113.6% year on year and by 737.9% over two years, showing a strong expansion trend. Profit also increased from €26.1K in 2023 to €40.2K in 2024 and €56.2K in 2025, although the margin declined from 41.8% to 16.4% and then to 10.8% as turnover expanded faster than earnings. The balance sheet strengthened over the period: total assets reached €114.7K in 2025, equity increased to €104.0K, and liabilities remained limited at €11.0K. Key ratios for 2025 indicate efficient use of capital, with ROE at 54.0%, ROA at 49.0%, debt-to-equity at 0.11, and asset turnover at 4.55x. Revenue per employee was €47.5K and profit per employee was €5.1K.